FollowMyHealth Patient Portal

Gerald L. Andriole Jr., MD

Robert Killian Royce Distinguished Professor
Professor, Surgery
Chief, Division of Urologic Surgery
Director, Men's Health Center

Specialty Areas

Urologic Surgery
Urologic Oncology
Prostate Cancer

Board Certifications

Urology

Hospital Affiliations

Progress West Hospital
Barnes-Jewish Hospital
Barnes-Jewish West County Hospital
St. Louis Children's Hospital
VA Medical Center - St. Louis

Areas of Clinical Interest

Prostate cancer, benign prostate hyperplasia, prostatectomy, penile cancer, bladder cancer, PSA, prostate specific antigen, BPH, kidney tumors, kidney cancer

  • Maps & Directions
  • Education
  • Publication & Research
  • In the News
  • Financial Disclosures
  • Videos

Maps & Directions

Maps & Directions

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129
Phone: 314-747-7222

Barnes-Jewish West County Hospital
Medical Building One

1040 N. Mason Road
Creve Coeur, MO 63141

Suite: Suite 122,
Barnes-Jewish West County Hospital
Office Phone: 314-362-8200
Fax: 314-361-2203

Center for Advanced Medicine
Urologic Surgery Center

4921 Parkview Place
St. Louis, MO 63110

Suite: C
Floor: 11
Office Phone: 314-362-8200
Fax: 314-361-2203

Education

Education

Fellowship: National Cancer Institute 1985
Residency: Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 1983
Residency: Surgery, Strong Memorial Hospital, University of Rochester, Rochester, New York 1980
Medical School: Jefferson Medical College, Philadelphia 1978
B.S.Accelerated Med.: Pennsylvania State University, State College, PA 1976

Publication & Research

Publication & Research

Prostatectomy versus Observation for Early Prostate Cancer.
Wilt TJ, Andriole GL, Brawer MK
N Engl J Med. 2017 Sep 28; 377(13)1302-3. doi: 10.1056/NEJMc1710384.

PMID:
    28953431
    [PubMed - indexed for MEDLINE]
Related citations


Sleep Problems Are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE.
Branche BL, Howard LE, Moreira DM, Roehrborn C, Castro-Santamaria R, Andriole GL, Hopp ML, Freedland SJ
J Urol. 2017 Sep 1; pii: S0022-5347(17)77428-9. doi: 10.1016/j.juro.2017.08.108.

PMID:
    28870861
    [PubMed - as supplied by publisher]
Related citations


Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.
Tsodikov A, Gulati R, Heijnsdijk EAM, Pinsky PF, Moss SM, Qiu S, de Carvalho TM, Hugosson J, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, Feuer EJ, de Koning HJ, Mariotto AB, Etzioni R
Ann Intern Med. 2017 Oct 3; 167(7)449-455. doi: 10.7326/M16-2586.

PMID:
    28869989
    [PubMed - indexed for MEDLINE]
Related citations


Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review.
Kane CJ, Eggener SE, Shindel AW, Andriole GL
Eur Urol Focus. 2017 Mar 11; pii: S2405-4569(16)30157-2. doi: 10.1016/j.euf.2016.10.010.

PMID:
    28753804
    [PubMed - as supplied by publisher]
Related citations


Follow-up of Prostatectomy versus Observation for Early Prostate Cancer.
Wilt TJ, Jones KM, Barry MJ, Andriole GL, Culkin D, Wheeler T, Aronson WJ, Brawer MK
N Engl J Med. 2017 Jul 13; 377(2)132-142. doi: 10.1056/NEJMoa1615869.

PMID:
    28700844
    [PubMed - indexed for MEDLINE]
Related citations


Brain signature and functional impact of centralized pain: a multidisciplinary approach to the study of chronic pelvic pain (MAPP) network study.
Kutch JJ, Ichesco E, Hampson JP, Labus JS, Farmer MA, Martucci KT, Ness TJ, Deutsch G, Apkarian AV, Mackey SC, Klumpp DJ, Schaeffer AJ, Rodriguez LV, Kreder KJ, Buchwald D, Andriole GL, Lai HH, Mullins C, Kusek JW, Landis JR, Mayer EA, Clemens JQ, Clauw DJ, Harris RE, MAPP Research Network.
Pain. 2017 Oct; 158(10)1979-1991. doi: 10.1097/j.pain.0000000000001001.

PMID:
    28692006
    [PubMed - in process]
Related citations


The combination of histological prostate atrophy and inflammation is associated with lower risk of prostate cancer in biopsy specimens.
Moreira DM, de O Freitas DM, Nickel JC, Andriole GL, Castro-Santamaria R, Freedland SJ
Prostate Cancer Prostatic Dis. 2017 Dec; 20(4)413-417. doi: 10.1038/pcan.2017.30.

PMID:
    28585572
    [PubMed - in process]
Related citations


Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.
Allott EH, Howard LE, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ
Cancer Prev Res (Phila). 2017 Jun; 10(6)319-326. doi: 10.1158/1940-6207.CAPR-17-0019.

PMID:
    28487295
    [PubMed - in process]
Related citations


Dutasteride is associated with reduced risk of transrectal prostate biopsy-associated urinary tract infection and related hospitalizations.
Moreira DM, Andriole GL, Nickel JC, Roehrborn CG, Castro-Santamaria R, Freedland SJ
World J Urol. 2017 Oct; 35(10)1525-1530. doi: 10.1007/s00345-017-2036-2.

PMID:
    28396999
    [PubMed - in process]
Related citations


Author Reply.
Kim EH, Shetty AS, Fowler KJ, Grubb RL 3rd, Andriole GL
Urology. 2017 Apr; 102196-197. doi: 10.1016/j.urology.2016.10.042.

PMID:
    28034526
    [PubMed - in process]
Related citations


Extent of Baseline Prostate Atrophy Is Associated With Lower Incidence of Low- and High-grade Prostate Cancer on Repeat Biopsy.
Freitas DM, Andriole GL Jr, Castro-Santamaria R, Freedland SJ, Moreira DM
Urology. 2017 May; 103161-166. doi: 10.1016/j.urology.2016.12.027.

PMID:
    28024967
    [PubMed - in process]
Related citations


Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study.
Feng T, Howard LE, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ
Int J Urol. 2017 Feb; 24(2)151-156. doi: 10.1111/iju.13265.

PMID:
    28004415
    [PubMed - in process]
Related citations


Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
Klaassen Z, Howard LE, Moreira DM, Andriole GL Jr, Terris MK, Freedland SJ
Prostate. 2017 Apr; 77(5)466-470. doi: 10.1002/pros.23285.

PMID:
    27990661
    [PubMed - indexed for MEDLINE]
Related citations


Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients With Estimated Risk of High-grade Prostate Cancer Less Than or Equal to 10.
Kim EH, Weaver JK, Shetty AS, Vetter JM, Andriole GL, Strope SA
Urology. 2017 Apr; 102183-189. doi: 10.1016/j.urology.2016.08.074.

PMID:
    27919668
    [PubMed - in process]
Related citations


Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.
Pinsky PF, Prorok PC, Yu K, Kramer BS, Black A, Gohagan JK, Crawford ED, Grubb RL, Andriole GL
Cancer. 2017 Feb 15; 123(4)592-599. doi: 10.1002/cncr.30474.

PMID:
    27911486
    [PubMed - indexed for MEDLINE]
Related citations


Determination of the Role of Negative Magnetic Resonance Imaging of the Prostate in Clinical Practice: Is Biopsy Still Necessary?
Wang RS, Kim EH, Vetter JM, Fowler KJ, Shetty AS, Mintz AJ, Badhiwala NG, Grubb RL 3rd, Andriole GL
Urology. 2017 Apr; 102190-197. doi: 10.1016/j.urology.2016.10.040.

PMID:
    27845218
    [PubMed - in process]
Related citations


Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel.
Kim EH, Andriole GL, Crawford ED, Sjoberg DD, Assel M, Vickers AJ, Lilja H
J Urol. 2017 Apr; 197(4)1041-1047. doi: 10.1016/j.juro.2016.10.089.

PMID:
    27810449
    [PubMed - in process]
Related citations


Symptom Variability and Early Symptom Regression in the MAPP Study: A Prospective Study of Urological Chronic Pelvic Pain Syndrome.
Stephens-Shields AJ, Clemens JQ, Jemielita T, Farrar J, Sutcliffe S, Hou X, Landis JR, MAPP Research Network.
J Urol. 2016 Nov; 196(5)1450-1455. doi: 10.1016/j.juro.2016.04.070.

PMID:
    27131464
    [PubMed - in process]
Related citations


Racial differences in prostate inflammation: results from the REDUCE study.
Vidal AC, Chen Z, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL, Taioli E, Fowke JH, Knudsen B, Drake CG, Nickel JC, Freedland SJ
Oncotarget. 2017 Sep 22; 8(42)71393-71399. doi: 10.18632/oncotarget.10690.

PMID:
    29069714
    [PubMed]
Related citations


Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic Health.
Fontana L, Cummings NE, Arriola Apelo SI, Neuman JC, Kasza I, Schmidt BA, Cava E, Spelta F, Tosti V, Syed FA, Baar EL, Veronese N, Cottrell SE, Fenske RJ, Bertozzi B, Brar HK, Pietka T, Bullock AD, Figenshau RS, Andriole GL, Merrins MJ, Alexander CM, Kimple ME, Lamming DW
Cell Rep. 2016 Jul 12; 16(2)520-530. doi: 10.1016/j.celrep.2016.05.092.

PMID:
    27346343
    [PubMed - in process]
Related citations

In the News

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following earned financial interests during calendar year 2016.

Company Name: Augmenix

Royalties:

Equity: Yes

Consulting/Advisory Board:

Speaker Fees:

Reporting Date: May 01, 2017

Videos

Videos